Logo image
Mechanism and nomenclature of methicillin resistance in Staphylococcus aureus and implications for testing interpretation and management: a position statement on behalf of the Staphylococcus aureus working groups ISAC-SAWG and ESCMID-ESGS
Journal article   Open access   Peer reviewed

Mechanism and nomenclature of methicillin resistance in Staphylococcus aureus and implications for testing interpretation and management: a position statement on behalf of the Staphylococcus aureus working groups ISAC-SAWG and ESCMID-ESGS

Kordo Saeed, Bibi C.G.C. Mason-Slingerland, Michael Z. David, Stefania Stefani, Marc Stegger, Margreet C. Vos and Robert Leo Skov
Clinical microbiology and infection, In Press
2026
PMID: 42863756
pdf
Published547.82 kBDownloadView
Open Access CC BY V4.0

Abstract

BORSA Cefoxitin MODSA MRSA OS-MRSA Staphylococcus aureus
Background Beyond mec-mediated resistance, Staphylococcus aureus has developed complex resistance mechanisms against antistaphylococcal β-lactam antibiotics. The scientific community lacks a unified consensus on the nomenclature/clinical implications of these mechanisms. Objectives This position statement by the members of Staphylococcus Working Groups of the International Society of Antimicrobial Chemotherapy and the European Society of Clinical Microbiology and Infectious Diseases propose a set of names for various types of methicillin/oxacillin reduced susceptibility/resistance in S. aureus. Content The Working Groups propose the following categorization: (1) mec-mediated methicillin-resistant S. aureus: This is due to mec (mecA or mecB or mecC)-mediated resistance. They can exhibit heteroresistant expression to methicillin. (2) Methicillin-resistant S. aureus lacking mec: Isolates are cefoxitin and/or oxacillin-resistant but mec-negative, and do not show heteroresistance. They can be subdivided into (2a) hyperproduction of β-lactamase and (2b) modifications of natural penicillin-binding proteins. Importantly, these mechanisms cannot easily be differentiated in routine laboratories. If the resistance mechanism is not fully characterized, using the name methicillin-resistant lacking mec is suggested. Isolates with hyperproduction of β-lactamase show low-level resistance to oxacillin, but most isolates test susceptible to cefoxitin. When the mechanism is characterized, we propose that they should be named hyper– β-lactamase-producing S. aureus instead of the hitherto used term borderline oxacillin-resistant S. aureus. For isolates with reistance due to modifications of the penicillin-binding proteins 1–4 in S. aureus, it is proposed to continue to name these modified S. aureus. Modified S. aureus isolates in routine diagnostic laboratories most commonly present as cefoxitin-resistant. (3) Oxacillin-susceptible mec-positive S. aureus: Strains carry a mec gene but harbour mutations, deletions, or insertion rendering them phenotypically susceptible to oxacillin/cefoxitin. Implications The proposed changes clarify methicillin resistance nomenclature in S. aureus, removing current ambiguity from clinical communication and literature. As novel methicillin resistance mechanisms emerge in S. aureus, the definition must be updated accordingly.

Details

Metrics

6 File views/ downloads
2 Record Views
Article has an altmetric score of 6

See more details

Posted by 10 X users
2 readers on Mendeley
Logo image